White Paper

Translating Engineered AAV Capsids Into Manufacturable Gene Therapies

Source: Viralgen

By Jacob Smith, Head of Technical Development and CMC Strategy, Viralgen, Sabrina Triffault, Study Director, Preclinical and Clinical Testing, GenoSafe, Laurence Jeanson-Leh, Quality Control Manager, GenoSafe, Jacob Staudhammer, Senior Principal, Dark Horse Consulting Group, and Daniel Lourenco, Senior Consultant, Dark Horse Consulting Group

GettyImages-1441343945-virus-viral-infection
Access The White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online